In vitro and in vivo evaluations of human papillomavirus type 16 (HPV16)-derived peptide-loaded dendritic cells (DCs) with a CpG oligodeoxynucleotide (CpG-ODN) adjuvant as tumor vaccines for immunotherapy of cervical cancer

By Wang Hua   Xu Hui   Lu Wei   Zhu Lin   Yu Yun   Hong Fan  

Archives of Gynecology and Obstetrics, Vol. 289, Iss. 1, 2014-01 ,pp. : 155-162

Springer Publishing Company

Access to resources Recommend Favorite

Seric and local antibodies against a synthetic peptide of HPV16

By Dreyfus M.   Baldauf J.-J.   Ritter J.   Obert G.  

European Journal of Obstetrics & Gynecology and Reproductive Biology, Vol. 59, Iss. 2, 1995-04 ,pp. : 187-191

Elsevier

Access to resources Recommend Favorite

Faut-il depister et traiter les lesions condylomateuses du partenaire masculin des patientes porteuses d'un CIN ?

By Aynaud O.   Leroy J.L.  

Gynecology Obstetrique & Fertilite, Vol. 31, Iss. 6, 2003-06 ,pp. : 562-566

Elsevier

Access to resources Recommend Favorite

The evaluation of proliferative activity in CIN III and microinvasive cervical cancer and its role in recurrence

By Tjalma W.   Weyler J.   Pollefliet C.   Bogers J.   Van Marck E.   van Dam P.   Buytaert P.  

European Journal of Obstetrics and Gynecology and Reproductive Biology, Vol. 94, Iss. 2, 2001-02 ,pp. : 270-275

Elsevier

Access to resources Recommend Favorite

Spontaneous evolution of intraepithelial lesions according to the grade and type of the implicated human papillomavirus (HPV)

By Syrjanen K.J.  

European Journal of Obstetrics & Gynecology and Reproductive Biology, Vol. 65, Iss. 1, 1996-03 ,pp. : 45-53

Elsevier

Access to resources Recommend Favorite